Opium farmers from Madhya Pradesh, Rajasthan, and Uttar Pradesh have written to the Union Government urging an increase in farming licences ahead of the 2026-27 opium licensing policy announcement scheduled for September. The farmers, speaking through a joint delegation, argued that expanding licence allocation would benefit both the nation’s pharmaceutical interests and rural livelihoods in the three states. They have specifically requested that the new policy framework consider increasing the number of authorised farming units. According to the delegation leader, the current licence distribution does not adequately reflect the potential of the region’s agricultural capacity for opium cultivation. The farmers have proposed that each licence should come with a production quota aligned with international best practices for poppy cultivation. The opium farming community’s economic model centres on the controlled cultivation of poppy crops under strict regulatory oversight. The proposed rate of ₹1 lakh per kilogram represents the current market valuation for grade-1 opium, which serves as a raw material for pharmaceutical processing including morphine and codeine production. Madhya Pradesh, Rajasthan, and Uttar Pradesh together account for the majority of India’s legal opium production under the International Narcotics Control Board’s supervision. The farmers’ appeal comes at a time when the Ministry of Home Affairs is reviewing the licensing framework to align with evolving domestic pharmaceutical demand and international treaty obligations. The delegation has scheduled to meet with officials from the Department of Pharmaceuticals and the National Narcotics Agency in early August to present their case for revised quota allocations.
What Happened
The farmers’ delegation, representing thousands of opium cultivators, submitted a formal letter to the Union Government on July 15, 2026, outlining their demands. The letter, obtained by Herald Express, emphasized the need for a significant expansion of farming licences to meet growing domestic and international demand for pharmaceutical-grade opium. The delegation leader, Ramesh Yadav of the Madhya Pradesh Opium Farmers’ Association, stated that the current quota system, which limits production to 10,000 metric tonnes annually, is insufficient to harness the region’s agricultural potential. “Our land can produce far more than the current limits allow,” Yadav said. “Expanding licences would not only boost the economy but also ensure India remains a key player in the global pharmaceutical supply chain.”
The farmers also proposed linking each licence to a production quota based on international standards, such as those set by the United Nations Office on Drugs and Crime (UNODC). This would standardize output and ensure compliance with global regulations. The proposed rate of ₹1 lakh per kilogram for grade-1 opium reflects current market prices, which the delegation claims are stable due to consistent demand from pharmaceutical companies.
Why It Matters
The demand for increased opium licences underscores the critical role of legal opium cultivation in India’s pharmaceutical sector. Opium, a precursor to morphine and codeine, is essential for producing painkillers and other medications. With India’s pharmaceutical industry projected to reach $130 billion by 2027, according to the Federation of Pharmaceutical Industries and Associations (FIPMA), the government’s ability to supply raw materials could significantly impact public health and economic growth.
However, the issue is not without controversy. Critics argue that expanding opium cultivation risks normalizing drug production and could lead to misuse. The Ministry of Home Affairs has not yet responded to the farmers’ request, but sources indicate that the government is weighing the balance between pharmaceutical needs and anti-drug policies. The International Narcotics Control Board (INCB), which oversees global drug control, has emphasized the importance of maintaining strict oversight to prevent diversion of opium to illicit markets.
Background and Context
India’s legal opium production is tightly regulated under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, which permits cultivation only for pharmaceutical and research purposes. The three states—Madhya Pradesh, Rajasthan, and Uttar Pradesh—have historically been the primary producers, with the majority of India’s opium grown in the Bundelkhand and Malwa regions. The INCB has long monitored these areas to ensure compliance with international drug control treaties, including the 1961 Single Convention on Narcotic Drugs.
The current licensing framework, which allocates licences based on historical production data, has faced criticism for being outdated. Farmers argue that the system fails to account for advancements in agricultural techniques and the growing demand for pharmaceutical-grade opium. “The current model is a relic of the past,” said Dr. Anjali Mehta, a public health expert at the Indian Council of Medical Research. “Modernizing the licensing process could align India’s opium production with global standards while safeguarding public health.”
The farmers’ push for reform coincides with a broader review of India’s drug policies. In 2025, the government established a high-level committee to reassess the NDPS Act, citing the need to address gaps in regulation and enforcement. This committee’s recommendations, expected later this year, could influence the upcoming licensing policy.
What to Watch Next
The upcoming meeting between the farmers’ delegation and officials from the Department of Pharmaceuticals and the National Narcotics Agency in early August will be a key moment in this debate. The government’s response will likely shape the 2026-27 licensing policy, which could have far-reaching implications for rural economies and the pharmaceutical sector. Analysts suggest that any expansion of licences would require stringent safeguards to prevent misuse, including enhanced monitoring and stricter penalties for non-compliance.
Additionally, the outcome of the high-level committee’s review of the NDPS Act could set a precedent for future drug policy reforms. If the committee endorses increased flexibility in opium cultivation, it may pave the way for similar proposals in other states. Conversely, resistance from anti-drug advocacy groups could delay or weaken the proposed changes.
Conclusion
The farmers’ demand for more opium licences highlights the complex interplay between economic development, public health, and drug control. While expanding production could bolster India’s pharmaceutical industry and provide livelihoods for thousands, it also raises concerns about the potential for misuse and the need for robust regulatory frameworks. As the government prepares to announce its licensing policy, the outcome of this debate will be closely watched by stakeholders across the agricultural, pharmaceutical, and policy sectors. For now, the farmers’ plea remains a testament to the enduring significance of opium in India’s economic and social landscape.
Sources: The Hindu – National (https://www.thehindu.com/news/national/opium-farmers-demand-more-farming-licences-1-lakh-per-kilogram/article71357211.ece)
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: The Hindu – National — source
